For example, Pan et al. developed a nanovector called Exo-PMA/Fe-HSA@DOX that was able to block the EGFR/AKT/NF-kB/IkB signaling pathway and achieve targeted therapy for PCa [167]. The gene discussed is AKT1; the disease is posterior cortical atrophy.